New York, NY -- (SBWIRE) -- 12/13/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: MGIC Investment Corp (NYSE:MTG), Synta Pharmaceuticals Corp (NASDAQ:SNTA), Dendreon Corporation (NASDAQ:DNDN), DCT Industrial Trust Inc (NYSE:DCT)
MGIC Investment Corp (NYSE:MTG) showed a volume of 6.17 million shares by the end of last trade whereas the average volume of the stock remained 6.10 million shares. The stock opened the session at $8.348.17 but then moved to $8.34. At that price, the stock showed a positive performance of 1.96%. MGIC Investment Corporation (MGIC) is a holding company and through wholly owned subsidiaries is a private mortgage insurer in the United States. As of December 31, 2012, its principal mortgage insurance subsidiaries, Mortgage Guaranty Insurance Corporation (MGIC) and MGIC Indemnity Corporation (MIC), were each licensed in all 50 states of the United States, the District of Columbia and Puerto Rico. During the year ending December 31, 2012, the Company wrote new insurance in each of those jurisdictions in MGIC and/or MIC.
Will MTG Continue To Move Higher? Find Out Here
Synta Pharmaceuticals Corp (NASDAQ:SNTA) opened the session at $5.02 and closed the session at $74.79. The stock showed a positive performance of 3.01% in previous trading session. Traded with volume of 5.97 million shares in the prior session and the average volume of the stock remained 12.09 million shares. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating multiple types of cancer and several drug candidates in the preclinical-stage of development. Its drug candidates are discovered and developed internally, using its chemical compound library and integrated discovery engine. During the year ended December 31, 2011,
For How Long SNTA will fight for Profitability? Read This Trend Analysis report
Dendreon Corporation (NASDAQ:DNDN) opened the session at $3.09 and closed the session at $3.21. The stock showed a positive performance of 4.56% in previous trading session. Traded with volume of 5.96 million shares in the prior session and the average volume of the stock remained 3.39 million shares. The beta of the stock remained 5.04. Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may significantly improve cancer treatment options for patients. The Company's product portfolio includes active cellular immunotherapies and a small molecule product candidate that could be applicable to treating multiple types of cancers. PROVENGE (sipuleucel-T),
Why Should Investors Buy DNDN After The Recent Gain? Just Go Here and Find Out
DCT Industrial Trust Inc (NYSE:DCT) the stock advanced 0.14% and finished the session at $7.11. The beta of the stock remained 1.55. DCT Industrial Trust Inc. (DCT) is an industrial real estate company that owns, operates and develops bulk distribution and light industrial properties in distribution markets in the United States and Mexico. The Company is structured as an umbrella partnership real estate investment trust (REIT), under which substantially all of its business is, and will be, conducted through a majority-owned and controlled subsidiary,
Will DCT Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)